J. Bergh

L. Holmberg, J. Bergh, G. Liljegren, 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Gene profile and response to treatment.

P. Hall, Y. Pawitan, E. Liu, 2005, Annals of Oncology.

Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?

J. Bergh, B. Långström, A. Lilja, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen

C. Fan, C. Perou, M. Ellis, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

A systematic overview of chemotherapy effects in breast cancer.

J. Bergh, P. Jönsson, B. Glimelius, 2001, Acta oncologica.

p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings.

L. Holmberg, J. Bergh, M. Inganäs, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Angiogenesis in invasive breast carcinoma--a prospective study of tumour heterogeneity.

J. Bergh, J. Ahlgren, B. Risberg, 2002, European journal of cancer.

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

A. Tutt, M. Piccart, C. Hudis, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Effect of granulocyte colony-stimulating factor (G-CSF)-supported chemotherapy on MR imaging of normal red bone marrow in breast cancer patients with focal bone metastases.

J. Bergh, H. Lindman, G. Åström, 2003, Acta radiologica.

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers.

L. Holmberg, J. Bergh, M. Inganäs, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer.

J. Bergh, P. Malmström, L. Hakamies‐Blomqvist, 2003, European journal of cancer.

The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer

J. Bergh, N. Tobin, T. Foukakis, 2015, Journal of internal medicine.

Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?

S. Swain, T. Foukakis, S. Swain, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF.

L. Holmberg, M. Inganäs, S. Klaar, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis

J. Bergh, J. Hartman, J. de Boniface, 2014, British Journal of Cancer.

Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patients.

M O Karlsson, J. Bergh, M. Karlsson, 2003, European journal of cancer.

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic breast cancer (MBC).

J. Bergh, V. Kataja, M. Colleoni, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiotherapy of breast cancer after breast-conserving surgery: an improved technique using mixed electron-photon beams with a multileaf collimator.

S. Asplund, J. Bergh, H. Lindman, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Breast cancer during follow-up and progression - A population based cohort on new cancers and changed biology.

J. Bergh, E. Karlsson, M. Bergenheim, 2014, European journal of cancer.

Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group.

L. Holmberg, J. Bergh, H. Adami, 1994, Journal of the National Cancer Institute.

Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.

R. Gray, T. Powles, C. Wilson, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

M. J. van de Vijver, C. Sotiriou, S. Loi, 2006, Journal of the National Cancer Institute.

PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients

M. Fernö, C. Perou, K. Czene, 2017, Clinical Cancer Research.

Short- and long-term anxiety and depression in women recalled after breast cancer screening.

J. Bergh, E. Thurfjell, C. Lampic, 2001, European journal of cancer.

Identification of molecular apocrine breast tumours by microarray analysis

D. Larsimont, M. Delorenzi, P. Farmer, 2005 .

Concordance among gene-expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen.

C. Fan, C. Perou, M. Ellis, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of drug interactions in the established FEC regimen in primary cultures of tumour cells from patients.

J. Bergh, R. Larsson, P. Nygren, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

M. J. van de Vijver, J. Bergh, S. Fox, 2006, Journal of the National Cancer Institute.

Prognostic Significance of Stromal Platelet-Derived Growth Factor (cid:1) -Receptor Expression in Human Breast Cancer

F. Pontén, T. Sjöblom, C. Heldin, 2009 .

Identification of molecular apocrine breast tumours by microarray analysis

David Cameron, Mauro Delorenzi, Jonas Bergh, 2005, Oncogene.

Tailored chemotherapy to equal toxicity: is it possible?

J. Bergh, J. Bergh, 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy.

L. Tabár, L. Holmberg, J. Bergh, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Early assessment of neoadjuvant chemotherapy by FEC-courses of locally advanced breast cancer using 99mTc-MIBI

H. Jacobsson, S. Larsson, E. Eriksson, 2003, Acta radiologica.

Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group.

J. Bergh, P. Malmström, L. Hakamies‐Blomqvist, 2000, European journal of cancer.

Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer

J. Bergh, C. Blomqvist, H. Joensuu, 2000, British Journal of Cancer.

Prognosis in women with a carcinoma in situ of the breast: a population-based study in Sweden.

L. Holmberg, J. Bergh, F. Wärnberg, 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer

N. Tobin, T. Foukakis, L. Petris, 2015, Journal of internal medicine.

The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage I. Results from a randomized trial.

L. Holmberg, J. Bergh, G. Liljegren, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

E. Winer, J. Cuzick, A. Tutt, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group.

H. Adami, G. Liljegren, S. Graffman, 1994, Journal of the National Cancer Institute.

When to order a biopsy to characterise a metastatic relapse in breast cancer.

J. Bergh, L. Lindström, T. Hatschek, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

Eld, M. Piccart, C. Hudis, 2014, Breast.

Early response of breast cancer bone metastases to chemotherapy evaluated with MR imaging.

J. Bergh, H. Lindman, K. Åström, 2001, Acta radiologica.

Suramin in non-small cell lung cancer and advanced breast cancer. Two parallel phase II studies.

J. Bergh, C. Rose, M. Mirza, 1997, Acta oncologica.

Skeletal metastases from breast cancer: uptake of 18F-fluoride measured with positron emission tomography in correlation with CT

J. Bergh, M. Bergström, G. Antoni, 1998, Skeletal Radiology.

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer.

V. Kataja, J. Bergh, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Hormone replacement therapy after breast cancer: attitudes of women eligible in a randomized trial

J. Bergh, N. Wilking, C. Bolund, 2009, Climacteric : the journal of the International Menopause Society.

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer.

J. Bergh, L. Jost, B. Pestalozzi, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.

J. Bergh, B. Berne, H. Lindman, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.